AVEROLOSIN 2 GM GR. 7 SACHETS

ABOUT STRONTIUM BONE METABOLISM MODULATOR ANTIOSTEOPOROTIC AGENT MECHANISM OF ACTION OF STRONTIUM STRONTIUM IS AN ANTIOSTEOPOROTIC AGENT WHICH BOTH INCREASES BONE FORMATION AND REDUCES BONE RESORPTION. STRONTIUM STIMULATES THE CALCIUM SENSING RECEPTORS AND LEADS TO THE DIFFERENTIATION OF PRE-OSTEOBLAST TO OSTEOBLAST WHICH INCREASES THE BONE FORMATION. STRONTIUM ALSO STIMULATES OSTEOBLASTS TO SECRETE OSTEOPROTEGERIN IN INHIBITING OSTEOCLASTS FORMED FROM PRE-OSTEOCLASTS IN RELATION TO THE RANKL SYSTEM WHICH LEADS TO THE DECREASE OF BONE RESORPTION INDICATIONS FOR STRONTIUM POSTMENOPAUSAL OSTEOPOROSIS INTERACTIONS FOR STRONTIUM FOOD MILK AND DERIVATIVE PRODUCTS AND MEDICINAL PRODUCTS CONTAINING CALCIUM MAY REDUCE THE BIOAVAILABILITY OF STRONTIUM MAY REDUCE THE ABSORPTION OF ORAL TETRACYCLINE AND QUINOLONE ANTIBIOTICS